Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 204–204 | Cite as

Ibrutinib

Decrease in the insulin antibodies and glutamic acid decarboxylase autoantibodies: 2 case reports
Case report
  • 16 Downloads

Reference

  1. Skrabs C, et al. Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia. Journal of Clinical Pharmacy and Therapeutics 43: 145-149, No. 1, Feb 2018. Available from: URL: http://doi.org/10.1111/jcpt.12602 -AustriaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations